The Namodenoson oral drug is well positioned in the field of anti-obesity agents due to its activity and favorable safety ...

This is the abrupt ending of a love romance said to have begun when the parties named a few months ago answered a matrimonial ...

A Palm Beach house built as a custom home for the former Apple chief who famously fired the company’s late co-founder Steve ...

Detailed price information for SPDR Kensho Future Security ETF (FITE-A) from The Globe and Mail including charting and trades.

The Mason County Lady Royals hosted the Bracken County Lady Bears in their second meeting of the 2024-25 season.

Can-Fite BioPharma has secured a US patent for Namodenoson, its lead drug candidate, for use as an anti-obesity treatment.

Can-Fite BioPharma (CANF) announced that its lead drug candidate Namodenoson was granted a patent for its use as an anti-obesity drug by the US ...

StockNews.com assumed coverage on shares of Can-Fite BioPharma (NYSE:CANF – Free Report) in a research report report published on Sunday morning. The brokerage issued a sell rating on the stock.

Can-Fite BioPharma Ltd. (NYSE: CANF), shares barely budged Monday as the biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncological and inflammatory ...